Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines

Psychopharmacology
U Malsch, M Kieser

Abstract

A 5-week randomized, placebo-controlled, double-blind study was carried out to investigate the efficacy of kava-kava special extract WS1490 in non-psychotic nervous anxiety, tension and restlessness states. During the first treatment week, the study dose drug was increased from 50 mg to 300 mg per day and pretreatment with benzodiazepines was tapered off over 2 weeks. These dosage adjustments were followed by 3 weeks of monotherapy with WS1490 or placebo. Outcome measures were the differences between baseline and end of treatment on the Hamilton Anxiety Scale (HAMA) and on a subjective well-being scale (Bf-S), as well as the benzodiazepine withdrawal symptoms. Changes in the Erlanger Anxiety, Tension and Aggression Scale (EAAS) and Clinical Global Impressions (CGI) were analyzed as secondary measures. Treatment safety was checked by interviews, adverse event reports and laboratory investigations. Forty patients (2x20) were included into the study. WS1490 was superior to placebo regarding the HAMA (P=0.01) and Bf-S (P=0.002) total scores and all secondary efficacy measures. The tolerance of WS1490 was not inferior to placebo. The study confirms the anxiolytic efficacy and good tolerance of WS1490 and shows that a further symptom...Continue Reading

Citations

Aug 5, 2003·Pharmacology, Biochemistry, and Behavior·E A Carlini
Oct 9, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·André RexHeidrun Fink
Oct 12, 2010·Nutrition Journal·Shaheen E Lakhan, Karen F Vieira
Mar 31, 2012·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Elham AlramadhanBenjamin S Weeks
Oct 18, 2002·CNS Drugs·Yadhu N Singh, Nirbhay N Singh
Jul 28, 2004·Journal of Herbal Pharmacotherapy·Ethan BaschEdzard Ernst
Jul 21, 2009·Journal of Psychiatric Research·Jerome SarrisGerard Byrne
Jan 23, 2009·Pharmacology, Biochemistry, and Behavior·Natalie R Bruner, Karen G Anderson
Oct 22, 2008·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Yuko YamazakiFumio Shimura
Apr 3, 2007·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·F Cícero Bezerra FelipeGlauce S de Barros Viana
Dec 4, 2003·Statistics in Medicine·Meinhard Kieser, Tim Friede
Jun 10, 2004·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·L ZouA Li
Sep 9, 2006·Psychosomatics·Bernardo NgScott C Matthews
Nov 1, 2001·The Cochrane Database of Systematic Reviews·M H Pittler, E Edzard
Apr 12, 2018·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Soo Liang OoiSok Cheon Pak
Oct 5, 2016·Statistical Methods in Medical Research·Martin PoschFrank Miller
Mar 11, 2004·Journal of Midwifery & Women's Health·Kira M Weier, Margaret W Beal
Jan 22, 2003·The Cochrane Database of Systematic Reviews·M H Pittler, E Ernst
Mar 16, 2017·Frontiers in Pharmacology·Hazrulrizawati A HamidMashitah M Yusoff
Feb 11, 2011·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Thalita Thais FaustinoRoberto Andreatini
Oct 31, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Samman MunirMohsin Khurshid
Aug 1, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Marilisa Pia DimmitoAdriano Mollica

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.